Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.173 billon in 2008. Novartis is one of the largest healthcare companies in the ...
We’re thrilled to announce that Novartis, a proudly Swiss company, is an official partner of the Eurovision Song Contest 2025, hosted in our headquarters city of Basel, Switzerland. Learn more Latest news Nov 27, 2024 Media Release Novartis Kisqali® receives European Commission approval in a...
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.173 billon in 2008. Novartis is one of the largest healthcare companies in the ...
International (1029 institutions) 89.2% Domestic (19 institutions) 10.8% Note: Hover over the graph to view the percentage of collaboration. Top 5 domestic collaborators with Novartis AG by Share Collaborating institutions Top 5 international collaborators with Novartis AG by Share Collaborating instit...
Hamad International Airport DohaHOK Completed Ph.: © Gia Chkhatarashvili The Bridge of Peace TbilisiaMDL arch. Michele De Lucchi Completed Ph.: Daniele Domenicali Epicenter Tokyo TokyoHerzog & de Meuron Completed Ph.: CGI images courtesy of Make Architects 20 Ropemaker Street LondonMake Architect...
The boards of directors of Novartis AG (Basel, Switzerland) and AstraZeneca PLC (London) have unanimously agreed to spin off and merge Novartis' Crop Protection and Seeds businesses and Zeneca Agrochemicals to create Syngenta AG, an agribusiness company with combined 1998 sales of US$7.9 billion....
Export Citation: Click for automatic bibliography generation Assignee: Novartis AG (Basel, CH) International Classes: A61K31/519;A61K31/4188;A61K31/496;A61K31/505;A61K31/506 View Patent Images: Download PDF 10220038 US Patent References: ...
Novartis AG (Basel, CH) Primary Class: 521/149 Other Classes: 424/497, 521/50, 521/82, 521/154, 521/159, 525/535, 525/538, 525/539, 525/540, 528/367, 528/369, 528/373, 528/398, 528/498 International Classes: A61L27/00;C08F290/06;C08G18/50;C08G18/81;C08G65/00;C08...
Assignee: NOVARTIS AG (Basel, CH) Primary Class: 514/210.18 International Classes: A61K31/506; A61K31/505 View Patent Images: Download PDF 20160235746 Related US Applications:20030091993 USE AND SCREENING METHOD FOR AN ABERRANT GENE PRODUCT-OPERATING SUBSTANCE...
Assignee: Novartis AG (Basel, CH) Primary Class: 435/5 Other Classes: 435/7.2, 435/7.22, 435/7.23, 435/7.31, 435/7.32, 435/7.33, 435/7.34, 435/7.36, 435/7.37 International Classes: C12Q1/70; G01N33/569; G01N33/571; G01N33/574 ...